PubMed · 2016 · 70 citations · 24 references
Open access
MedicineCell BiologyOncologyCell SignalingSignal TransductionTumor MicroenvironmentCancer Cell SignalingCancer-associated FibroblastsSignal Transduction In CancerStromal Cell InteractionsTumor Microenvironment InteractionsTumor-stroma InteractionsCancer-associated Fibroblast SignalingExosome HeterogeneityExosome SignalingExosomesExosomes In CancerExosomes In Stroma CommunicationExosomes In Tumor CommunicationTumor-derived Exosomes
Transforming growth factor-beta (TGFβ) signaling in cancer is context dependent and acts either as a tumor suppressor or a tumor promoter. Loss of function mutation in TGFβ type II receptor (TβRII) is a frequent event in oral cavity squamous cell carcinoma (SCC). Recently, heterogeneity of TGFβ response has been described at the leading edge of SCC and this heterogeneity has been shown to influence stem cell renewal and drug resistance. Because exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways we investigated whether exosomes contain components of the TGFβ signaling pathway and whether exosome transfer between stromal fibroblasts and tumor cells can influence TGFβ signaling in SCC. We demonstrate that exosomes purified from stromal fibroblasts isolated from patients with oral SCC contains TβRII. We also demonstrate that transfer of fibroblast exosomes increases TGFβ signaling in SCC keratinocytes devoid of TβRII which remain non-responsive to TGFβ ligand in the absence of exosome transfer. Overall our data show that stromal communication with tumor cells can direct TGFβ signaling in SCC.
24
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Comprehensive genomic characterization of head and neck squamous cell carcinomas